These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17075523)

  • 1. [Nerve excitability studies in the assessment of dysimmune neuropathies].
    Lefaucheur JP; Boërio D; Hogrel JY; Créange A
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 1():3S17-3S26. PubMed ID: 17075523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Axonal involvement in dysimmune neuropathies].
    Vallat JM
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S5-11. PubMed ID: 18087224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease.
    Krishnan AV; Phoon RK; Pussell BA; Charlesworth JA; Bostock H; Kiernan MC
    Clin Neurophysiol; 2006 May; 117(5):992-9. PubMed ID: 16516547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage.
    Kanai K; Kuwabara S; Misawa S; Tamura N; Ogawara K; Nakata M; Sawai S; Hattori T; Bostock H
    Brain; 2006 Apr; 129(Pt 4):953-62. PubMed ID: 16467388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conduction blocks and peripheral neuropathies].
    Kuntzer T; Magistris MR
    Rev Neurol (Paris); 1995; 151(6-7):368-82. PubMed ID: 7481400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in excitability properties associated with axonal regeneration in human neuropathy and mouse Wallerian degeneration.
    Sawai S; Kanai K; Nakata M; Hiraga A; Misawa S; Isose S; Hattori T; Kuwabara S
    Clin Neurophysiol; 2008 May; 119(5):1097-105. PubMed ID: 18342570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiology in demyelinating polyneuropathies.
    Franssen H
    Expert Rev Neurother; 2008 Mar; 8(3):417-31. PubMed ID: 18345972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Channels, currents and mechanisms of accommodative processes in simulated cases of systematic demyelinating neuropathies.
    Stephanova DI; Daskalova M; Alexandrov AS
    Brain Res; 2007 Sep; 1171():138-51. PubMed ID: 17706617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity-dependent modulation of axonal excitability in unmyelinated peripheral rat nerve fibers by the 5-HT(3) serotonin receptor.
    Lang PM; Moalem-Taylor G; Tracey DJ; Bostock H; Grafe P
    J Neurophysiol; 2006 Dec; 96(6):2963-71. PubMed ID: 16956988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischaemia induces paradoxical changes in axonal excitability in end-stage kidney disease.
    Krishnan AV; Phoon RK; Pussell BA; Charlesworth JA; Bostock H; Kiernan MC
    Brain; 2006 Jun; 129(Pt 6):1585-92. PubMed ID: 16636020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in potentials and excitability properties in simulated cases of demyelinating neuropathies. Part III. Paranodal internodal demyelination.
    Stephanova DI; Daskalova M
    Clin Neurophysiol; 2005 Oct; 116(10):2334-41. PubMed ID: 16122981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dysimmune peripheral neuropathies: evaluation of treatment].
    Nicolas G
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S77-84. PubMed ID: 18087234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy.
    Krishnan AV; Lin CS; Kiernan MC
    Brain; 2008 May; 131(Pt 5):1209-16. PubMed ID: 18362098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of nerve excitability in toxic and metabolic neuropathies.
    Krishnan AV; Lin CS; Park SB; Kiernan MC
    J Peripher Nerv Syst; 2008 Mar; 13(1):7-26. PubMed ID: 18346228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axonal ionic pathophysiology in human peripheral neuropathy and motor neuron disease.
    Kuwabara S; Misawa S
    Curr Neurovasc Res; 2004 Oct; 1(4):373-9. PubMed ID: 16181085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Altered axonal ion channel function in amyotrophic lateral sclerosis].
    Kuwabara S; Kanai K
    Brain Nerve; 2007 Oct; 59(10):1109-15. PubMed ID: 17969351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative bioptic and electrophysiological investigations in polyneuropathies (author's transl)].
    Sluga E; Mamoli B; Pateisky K
    Wien Klin Wochenschr; 1977 Feb; 89(4):113-22. PubMed ID: 836614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve conduction and excitability studies in peripheral nerve disorders.
    Krarup C; Moldovan M
    Curr Opin Neurol; 2009 Oct; 22(5):460-6. PubMed ID: 19625961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of electrophysiology in the follow-up of dysimmune polyneuropathies].
    Léger JM
    Rev Med Liege; 2004; 59 Suppl 1():124-32. PubMed ID: 15244168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nerve conduction blocks and peripheral neuropathies].
    Lefaucheur JP; Boërio D; Créange A
    J Soc Biol; 2006; 200(4):307-21. PubMed ID: 17652968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.